ArticleACS medicinal chemistry letters2017

Development of 4-Heteroarylamino-1'-azaspiro[oxazole-5,3'-bicyclo[2.2.2]octanes] as α7 Nicotinic Receptor Agonists.

Matthew D Hill et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.